HSBC is moving to fill a big gap left by SVB's collapse. And they've recruited some familiar faces for the leap
British banking giant HSBC was the first big player to step up to fill the gap left by SVB’s abrupt collapse, buying the UK end of the business for all of £1 a month ago.
Now they’re jumping the pond to scoop up opportunities in the US, recruiting dozens of staffers out of the old SVB organization to create a new banking unit. And HSBC is absorbing a lineup of talent that’s spent decades building banking relationships that are rooted deep in biotech.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.